AI for biotech
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
1,035
NCT00404404
ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast Cancer
Phase: Phase 2
Role: Lead Sponsor
Start: Oct 31, 2006
Completion: Not specified
NCT03896958
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Phase: N/A
Role: Collaborator
Start: Mar 21, 2019
Completion: Mar 12, 2024
Loading map...